NO922475L - Imidazolforbindelser, fremgangsmaate for fremstilling derav samt anvendelse derav for fremstilling av farmasoeytiske preparater - Google Patents

Imidazolforbindelser, fremgangsmaate for fremstilling derav samt anvendelse derav for fremstilling av farmasoeytiske preparater

Info

Publication number
NO922475L
NO922475L NO92922475A NO922475A NO922475L NO 922475 L NO922475 L NO 922475L NO 92922475 A NO92922475 A NO 92922475A NO 922475 A NO922475 A NO 922475A NO 922475 L NO922475 L NO 922475L
Authority
NO
Norway
Prior art keywords
preparing
pharmaceutical preparations
procedures
imidazole compounds
preparing pharmaceutical
Prior art date
Application number
NO92922475A
Other languages
English (en)
Other versions
NO922475D0 (no
NO302119B1 (no
Inventor
Oskar Axelsson
Mikkel Thaning
Peter Moldt
Original Assignee
Neurosearch As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Neurosearch As filed Critical Neurosearch As
Publication of NO922475D0 publication Critical patent/NO922475D0/no
Publication of NO922475L publication Critical patent/NO922475L/no
Publication of NO302119B1 publication Critical patent/NO302119B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/24—Benzimidazoles; Hydrogenated benzimidazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
    • C07D235/30—Nitrogen atoms not forming part of a nitro radical
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Lubricants (AREA)
  • Eye Examination Apparatus (AREA)
  • Magnetic Resonance Imaging Apparatus (AREA)
NO922475A 1991-06-24 1992-06-23 Imidazolforbindelser, farmasöytiske preparater som omfatter en slik forbindelse, samt anvendelser derav for fremstilling av farmasöytiske preparater NO302119B1 (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US72002191A 1991-06-24 1991-06-24

Publications (3)

Publication Number Publication Date
NO922475D0 NO922475D0 (no) 1992-06-23
NO922475L true NO922475L (no) 1992-12-28
NO302119B1 NO302119B1 (no) 1998-01-26

Family

ID=24892332

Family Applications (1)

Application Number Title Priority Date Filing Date
NO922475A NO302119B1 (no) 1991-06-24 1992-06-23 Imidazolforbindelser, farmasöytiske preparater som omfatter en slik forbindelse, samt anvendelser derav for fremstilling av farmasöytiske preparater

Country Status (14)

Country Link
EP (1) EP0520200B1 (no)
JP (1) JPH05186432A (no)
AT (1) ATE163290T1 (no)
AU (1) AU653816B2 (no)
CA (1) CA2071793A1 (no)
DE (1) DE69224448T2 (no)
DK (1) DK0520200T3 (no)
ES (1) ES2113898T3 (no)
FI (1) FI922905L (no)
GR (1) GR3026467T3 (no)
IE (1) IE921650A1 (no)
NO (1) NO302119B1 (no)
NZ (1) NZ242951A (no)
ZA (1) ZA924117B (no)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK40192D0 (da) * 1992-03-26 1992-03-26 Neurosearch As Imidazolforbindelser, deres fremstilling og anvendelse
DK154092D0 (da) * 1992-12-23 1992-12-23 Neurosearch As Imidazolforbindelser, deres fremstilling og anvendelse
AU675484B2 (en) * 1993-03-24 1997-02-06 Neurosearch A/S Benzimidazole compounds, their use and preparation
US5554630A (en) * 1993-03-24 1996-09-10 Neurosearch A/S Benzimidazole compounds
US5496826A (en) * 1994-09-02 1996-03-05 Bristol-Myers Squibb Company Pharmaceutical methods of using heterocyclic derivatives of N-phenylamides
ES2150671T3 (es) * 1995-04-21 2000-12-01 Neurosearch As Compuesto de bencimidazol y su utilizacion como moduladores del complejo de receptores gaba-a.
DE69833858T2 (de) * 1997-07-08 2007-02-22 Ono Pharmaceutical Co. Ltd. Aminosäurederivate
US6350762B1 (en) 1997-12-22 2002-02-26 Ajinomoto Co., Inc. Dihydropyridine derivative
TWI245035B (en) 1998-06-26 2005-12-11 Ono Pharmaceutical Co Amino acid derivatives and a pharmaceutical composition comprising the derivatives
DE69924493T2 (de) * 1998-07-02 2005-09-15 Neurosearch A/S Kaliumkanal-blockierende mittel
US6194447B1 (en) 1998-07-02 2001-02-27 Neurosearch A/S Bis (benzimidazole) derivatives serving as potassium blocking agents
EP1097929A4 (en) 1998-07-14 2005-12-21 Ono Pharmaceutical Co AMINO ACID DERIVATIVES AND MEDICAMENTS IN WHICH THESE DERIVATIVES ARE THE ACTIVE INGREDIENTS
AU4329499A (en) 1998-07-30 2000-02-21 Warner-Lambert Company Reduced dipeptide analogues as calcium channel antagonists
AU5568200A (en) 1999-06-23 2001-01-09 Ajinomoto Co., Inc. Dihydropyridine derivative
US7115645B2 (en) 2000-01-14 2006-10-03 Schering Aktiengesellschaft 1,2 diarylbenzimidazoles and their pharmaceutical use
IL150150A0 (en) * 2000-01-14 2002-12-01 Schering Ag 1,2-diaryl benzimidazoles for treating illnesses associated with a microglia activation
US7329679B2 (en) 2000-01-27 2008-02-12 Schering Aktiengesellschaft 1,2 Diarylbenzimidazoles and their pharmaceutical use
DE10135050A1 (de) * 2001-07-09 2003-02-06 Schering Ag 1-Ary1-2-N-, S- oder O-substituierte Benzimidazolderivate, deren Verwendung zur Herstellung von Arzneimitteln sowie diese Derivate enthaltende pharmazeutische Präparate
DE10207844A1 (de) * 2002-02-15 2003-09-04 Schering Ag 1-Phenyl-2-heteroaryl-substituierte Benzimidazolderivate, deren Verwendung zur Herstellung von Arzneimitteln sowie diese Derivate enthaltende pharmazeutische Präparate
KR100873400B1 (ko) * 2002-10-17 2008-12-11 한국과학기술연구원 Ｎ-타입 칼슘 채널의 활성을 억제함으로써 우울증을감소시키는 방법

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4492708A (en) * 1982-09-27 1985-01-08 Eli Lilly And Company Antiviral benzimidazoles
JPS6474A (en) * 1987-01-29 1989-01-05 Otsuka Pharmaceut Factory Inc Benzimidazole derivative
JPH0772181B2 (ja) * 1989-06-26 1995-08-02 株式会社大塚製薬工場 ベンズイミダゾール誘導体
NZ239540A (en) * 1990-09-24 1993-11-25 Neurosearch As 1-phenyl benzimidazole derivatives and medicaments

Also Published As

Publication number Publication date
EP0520200B1 (en) 1998-02-18
EP0520200A3 (en) 1993-05-12
DK0520200T3 (da) 1998-09-23
FI922905A7 (fi) 1992-12-25
NZ242951A (en) 1994-12-22
ZA924117B (en) 1993-03-31
IE921650A1 (en) 1992-12-30
JPH05186432A (ja) 1993-07-27
NO922475D0 (no) 1992-06-23
FI922905L (fi) 1992-12-25
DE69224448D1 (de) 1998-03-26
CA2071793A1 (en) 1992-12-25
GR3026467T3 (en) 1998-06-30
FI922905A0 (fi) 1992-06-22
AU653816B2 (en) 1994-10-13
EP0520200A2 (en) 1992-12-30
AU1726792A (en) 1993-01-07
NO302119B1 (no) 1998-01-26
ES2113898T3 (es) 1998-05-16
DE69224448T2 (de) 1998-06-10
ATE163290T1 (de) 1998-03-15

Similar Documents

Publication Publication Date Title
AU653816B2 (en) Imidazole compounds, their preparation and use
CS553490A3 (en) Transdermal therapeutic system
FI961809A0 (fi) Uudet (R)-5-karbamoyyli-8-fluori-3-N,N-disubstituoitu-amino 3,4-dihydro-2H-1-bentsopyraanit
CA2086434A1 (en) Quinuclidine derivatives
HU9302496D0 (en) Method for producing anti-viral nucleoside combinations and one for preparing medical preparatives containing said compounds
BG101118A (en) Therapeutical compounds
FI862011A0 (fi) Terapeutiska nukleosider.
NO923975L (no) 2-aminometyl-kromaner
DE69825292D1 (de) Verwendung von inosine zur herstellung eines medikamentes zur stimulierung des axonwachstums von zns-neuronen
FI935134A0 (fi) Substituerade 3-aminokinuklidiner
TR199802667T2 (xx) Spiro-piperidin t�revleri ve terap�tik ajan olarak kullan�mlar�.
ES2043025T3 (es) Un procedimiento para preparar una composicion farmaceutica que contiene acido 3-(aminopropil)metil-fosfinico como agente terapeutico.
MX9200361A (es) Nuevo uso del antagonista de adenosina.
LV10186A (lv) Cistina atvasinajumu pielietojums arstniecibas lidzeklu ar imunomodulejosu darbibu pagatavosanai farmaceitiskas kompozicijas uz to bazes
NO943837L (no) Terapeutisk aktive derivater av 1-naftylpyrazol-3-karboksamider, fremstilling av slike derivater, samt farmasöytiske preparater
PT656209E (pt) Derivados de melatonina para uso no tratamento de perturbacoes de dessincronizacao
PL310950A1 (en) Novel imidazole quinoxalinones, method of obtaining them and their application
SE8703308L (sv) Terapeutiskt medel for behandling av sjukdomar forbundna med cerebral ischemi
ZA893310B (en) Novel strobilurine derivatives,their preparation and their use
ITRM910085A0 (it) Prodotto farmaceutico per la terapia dei tumori, in particolare di quelli ovarici e del sistema emopoietico, contenente quercitina come principio attivo.
ZA872263B (en) Indole derivatives,processes for their preparation and pharmaceutical composition for the treatment for migraine
NO166280C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive n,n'-disubstituerte ureaer.
IT1258803B (it) Composizioni farmaceutiche comprendenti melatonina o un suo derivato-agonista, atte al trattamento dei disordini cerebro-vascolari
IT1274012B (it) N-acetiltriptamine-2-sostituite, antagoniste ad elevata affinita' del recettore della melatonina

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees

Free format text: LAPSED IN DECEMBER 2000